DISCLAIMER — Not financial advice. Educational content only, not an offer or solicitation to buy or sell any security. Biotech and small/mid-cap stocks are highly speculative and volatile and can result in a partial or total loss of capital. Do your own research and consult a licensed advisor where appropriate. / Contenuti a solo scopo informativo e didattico, non costituiscono consulenza finanziaria né offerta o sollecitazione al pubblico risparmio ai sensi delle normative CONSOB e SEC. Le azioni biotech e le small/mid cap sono strumenti altamente speculativi e volatili e possono comportare la perdita parziale o totale del capitale investito. Si raccomanda di effettuare sempre le proprie ricerche e, se necessario, di rivolgersi a un consulente abilitato.
Merlintrader Trading Pub
Biotech catalyst news and analysis. FDA PDUFA tracker
Merlintrader Trading Pub
Biotech catalyst news and analysis. FDA PDUFA tracker
Run-Up to Profit
Biotech Catalyst Course & Framework — 5-Chapter Masterclass
From Beginner to a Structured Biotech Catalyst Framework in 5 Days
Learn a clear, repeatable framework to identify and analyze biotech catalysts with more awareness. The focus is education and process, not signals or promises of profit.
Educational only: this course does not provide investment advice, trading signals or guarantees of results. Any decision to buy, sell or hold a security remains entirely your responsibility.
What You’ll Learn
This 5-chapter course walks you through a complete biotech catalyst framework. Whether you’re new to biotech or looking to sharpen your process, it covers the key elements you need to analyze small-cap biotech opportunities with a structured, risk-aware mindset.
Course Highlights:
- Understand the main catalyst types (FDA, clinical, earnings, partnerships, conferences)
- Read and interpret clinical trial results with more confidence
- Master PDUFA timelines and think in terms of probabilities, not certainties
- Build simple but solid biotech valuation frameworks
- Spot potential red and green flags before and after key dates
- Study real examples from AGIO, NUVB and other recent catalysts
- Clarify best practices for risk management around catalyst events
All concepts are for educational purposes only and are not recommendations to trade any specific ticker or strategy.
The 5-Chapter Structure
1
Catalyst Trading Guide
Understand catalyst types, market patterns and historical impact. Learn what tends to move biotech stocks and how traders often think about entries and exits around events.
Topics: FDA, clinical, earnings, partnership and conference catalysts
Duration: 12–15 min read | ~3,200 words
Start Chapter 1 →2
How to Read Trial Results
Decode clinical trial data with a more professional lens. Understand primary and secondary endpoints, statistical significance and safety signals in a practical way.
Topics: Phase 1/2/3, endpoints, p-values, real-world examples
Duration: 12–15 min read | ~3,500 words
Start Chapter 2 →3
PDUFA Decisions Explained
Explore FDA approval timelines, review types and typical stock reaction patterns. Learn to think in terms of scenarios and probabilities instead of trying to “predict the future”.
Topics: Priority vs standard review, approval rates, stock impact patterns
Duration: 12–15 min read | ~3,000 words
Start Chapter 3 →4
Biotech Valuation Framework
Build simple, transparent valuation frameworks. Understand market cap, peak sales estimation and basic risk-adjusted thinking to compare different biotech stories.
Topics: Valuation multiples, peak sales, comparables, practical implications
Duration: 12–15 min read | ~4,000 words
Start Chapter 4 →5
Red/Green Flags Assessment
Learn to map potential risks and opportunities before a catalyst. Apply a due diligence checklist to avoid the most obvious traps and understand what you are really betting on.
Topics: Safety signals, competition, management, cash runway and dilution
Duration: 12–15 min read | ~3,500 words
Start Chapter 5 →Learning Path
Recommended Sequence:
- Chapter 1: Catalyst fundamentals (foundation for everything else)
- Chapter 2: Trial result interpretation (how to read clinical data in context)
- Chapter 3: PDUFA and regulatory timelines (how the FDA process works)
- Chapter 4: Valuation frameworks (how the market may try to price stories)
- Chapter 5: Due diligence checklist (how to map risks vs potential upside)
Timeline: one chapter per day ≈ 5-day intensive, or spread across 2–3 weeks for deeper study and additional research.
Course Stats
5
Chapters
17,000+
Words
60+
Minutes (reading time)
∞
Reusable Frameworks
Who This Course Is For
- Beginner traders approaching biotech for the first time
- Experienced traders who want a more systematic biotech process
- Investors wanting to understand biotech fundamentals and catalyst dynamics
- Portfolio managers evaluating small-cap or niche biotech ideas
- Anyone interested in understanding and possibly navigating catalyst-driven volatility, fully aware of the risks involved
What Makes This Course Different
Real Data, Real Examples
Instead of hypothetical scenarios, we use real case studies from recent catalysts such as AGIO (RISE UP setback, around −50%) and NUVB (IBTROZI launch, strong performance year-to-date), among others. Past performance is purely illustrative and does not guarantee or predict future results.
Coherent System, Not Random Notes
The chapters are designed to build on each other. The idea is not to give you “hot tips”, but a coherent map you can integrate into your own research and decision-making process, if you choose to trade biotech.
Evergreen Principles
Individual tickers change, but catalyst types, regulatory logic and valuation principles tend to remain valid over time. The examples can be updated, while the underlying frameworks stay relevant as a reference.
Getting Started
Ready to study biotech catalyst dynamics with a clearer structure? Start with Chapter 1 and move at your own pace. Each chapter includes:
- Detailed explanations of core concepts
- Real-world examples and case studies
- Discussion of typical trading and risk-management approaches
- Tables, checklists and reusable frameworks
- Internal links to related tools and resources on Merlintrader
Nothing in this course is a recommendation to buy or sell any security. Always cross-check information with official sources (SEC, FDA, company press releases) before making decisions.
Start your 5-chapter masterclass journey here:
Scanner for active traders
Try ChartsWatcher free, then unlock 10% OFF with SAVE10
ChartsWatcher is a real-time scanner for momentum traders: fast movers, unusual volume and rotations — so you can focus on the few tickers that matter right now, instead of watching hundreds of charts.
Start with the free version. When you upgrade, use SAVE10 for 10% OFF your first paid period.
Start free – then use SAVE10
No credit card required to start. Apply SAVE10 when upgrading.
Recommended platform
One platform. All your brokers.
Medved Trader connects multiple brokers in one workspace, with pro charts, hotkeys and fast execution — without changing your broker accounts.
A single cockpit for positions, Level II and multi-broker order routing, built for active day & swing traders.
Get 1 Month Free ➔
Multi-broker workflow + customizable layouts in one platform.
Monica.im – the AI assistant I use every day
If you find value in the work I publish on Merlintrader and want a practical AI assistant for research and writing, you can sign up using this referral link. Click here to try Monica.im and support the site
Find out how I use AI on Merlintrader: AI, retail and Merlintrader
Disclosure: some of the links in the promotional blocks above are affiliate or referral links. If you choose to subscribe or sign up through them, Merlintrader may receive a small commission or benefit at no extra cost to you.
